Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Connective Tissue Disorders Lack Societal Concern, Financial Support

Simon M. Helfgott, MD  |  Issue: September 2015  |  September 15, 2015

For some, this approach may not suffice, and other injectable solutions have been proposed, including the use of platelet-rich-plasma injections. The platelet-rich component is thought to contain numerous growth factors that help heal injuries. The technique has been popularized by its use in star athletes, such as Tiger Woods and Rafael Nadal, although the data demonstrating its efficacy are lacking.6

Do Entheses Hold the Clue to Spondyloarthritis (SpA)?

Over the past decade, nothing in the field of tendon biology has captivated the minds of rheumatologists as much as the enthesis, the intricate fibrocartilaginous structure comprising the bone–tendon interface. Unlike the rest of the tendon, it is rich in type II collagen, produced by chondrocyte-like cells not found in other tendon regions.5 The enthesis has been considered to be a key target in SpA.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

A fascinating study in a mouse model of ankylosing spondylitis described the potential role of IL-23 and entheseal-resident T cells in the pathogenesis of SpA.7 Recall that HLA-B27 has a tendency to misfold, and this misfolding results in the production of IL-23. IL-23 is also produced in response to the endoplasmic reticulum stress response that is triggered by Chlamydia trachomatis, a bacterium that is associated with the reactive arthritis subtype of SpA. Taken together, these observations suggest that overproduction of, or heightened sensitivity to, IL-23 may be central to the pathogenesis of SpA.

Various pathways may lead to elevated IL-23 expression, which can activate a previously unidentified population of resident T cells within the enthesis. These activated T cells can then promote local inflammation and bone remodeling through a variety of effector mediators, including IL-17 and IL-22. The net result of these actions is the typical ankylosed appearance of the spine.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

In this study, investigators also detected inflammatory changes in the aortic root and valve, which are structurally similar to the entheses and some mice developed psoriatiform skin lesions. Why the enthesis has the potential to serve as a potent site for inflammation, particularly in SpA, remains an enigma. Could IL-23 be the link that binds immunity to our body’s scaffolding?

Why Tendons Matter

Defining the source of musculoskeletal pain is at the heart of what we do as rheumatologists. Patients seek answers and solutions to their ailments. Too often, their complaints of pain, stiffness and soreness are either ignored or lumped together by various practitioners who have a tendency to overuse the moniker, arthritis. Sorry, there’s not much we can do about your arthritis pain, you just have to live with it.

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:ConditionsOpinionResearch RheumRheuminationsSoft Tissue PainSpeak Out Rheum Tagged with:bursitisconnective tissue disorderpatient careResearchrheumatologisttendonitis

Related Articles

    A Duet of Bone and the Immune System

    July 12, 2011

    Examining emerging perspectives in osteoimmunology

    The Classification Challenge of Pediatric Spondylarthritis

    April 1, 2010

    Condition often confused with other disorders

    Case Report: A Psoriatic Arthritis Patient with Dactylitis & Enthesitis

    September 20, 2018

    A 36-year-old woman presented at the Johns Hopkins Arthritis Center for a second opinion regarding a diagnosis of psoriatic arthritis (PsA). One year prior to our evaluation, she had developed pain and stiffness in her hands, feet, knees, ankles, elbows and shoulders. She had mild plaque psoriasis of the scalp and base of the neck,…

    Treating Early-Stage Spondyloarthritis May Prevent Disease Progression, Say Researchers at the ACR/ARHP Winter Rheumatology Symposium

    April 2, 2014

    Therapy with tumor necrosis factor inhibitors, nonsteroidal antiinflammatory drugs, ustekinumab in early stages of osteitis may halt molecular switching to bone-forming phenotype characteristic of SpA

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences